Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions
Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral format Collaboration further advances Biogen's immunology strategy by broadening its early-stage pipeline and incorporating an additional clinically v
(Financial Post, 2025-11-24T12:30:38Z)